What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study

BMJ Open

Volumn 6, Issue 1, 2016, Pages

  Parsons, Suzanne ^a   Starling, Bella ^a   Mullan Jensen, Christine ^b   Tham, Su Gwan ^c   Warner, Kay ^d   Wever, Kim ^e  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b Fresheyes Research   (Ireland)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e Research and International Affairs   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MEDICAL RESEARCH; MEDICINE; PATIENT PARTICIPATION; POLAND; PROFESSIONAL KNOWLEDGE; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; SOCIAL PARTICIPATION; SPAIN; TELEPHONE INTERVIEW; THEMATIC ANALYSIS; UNITED KINGDOM; COMMUNITY PARTICIPATION; DRUG DEVELOPMENT; EUROPE; INTERVIEW;

COMMUNITY PARTICIPATION; DRUG DISCOVERY; DRUG INDUSTRY; EUROPE; HUMANS; INTERVIEWS AS TOPIC; PATIENT PARTICIPATION; POLAND; QUALITATIVE RESEARCH; SPAIN; UNITED KINGDOM;

EID: 84960408223     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-008928     Document Type: Article

References (24)

1. Coulter A, Askham J, Parsons S. Where are the patients in decision making about their own care? WHO Regional Office for Europe, 2008:1-14.
2. Nelson EC, Eftimovska E, Lind C, et al. Patient reported outcome measures in practice. BMJ2015;350:g7818.
3. Coulter A, Locock L, Ziebland S, et al. Collecting data on patient experience is not enough: they must be used to improve care. BMJ 2014;348:g2225.
4. Boote J, Wong R, Booth A. 'Talking the talk or walking the walk?' A bibliometric review of the literature on public involvement in health research published between 1995 and 2009. Health Expect 2015;18:44-57.
5. Moors E, Cohen AF, Schellekens H. Towards a sustainable system of drug development. Drug Discov Today 2014;19:1711-20.
6. Grogan K. Pharma optimistic about future, worried about reputation. Pharma Times online. http://www.pharmatimes.com/mobile/14-06-13/pharma-optimistic-about.-future-worried-about- reputation.aspx?r=1 (13 June 2014). (accessed 18 Mar 2015).
7. Smits E, Boon W. The role of users in innovation in the pharmaceutical industry. Drug Discov Today 2008;13:353-9.
8. Houyez F. Active involvement of patients in drug research, evaluation and commercialisation: European perspective. J Ambul Care Manage 2004;27:139-45.
9. INVOLVE website. http://www.invo.org.uk (accessed 17 Mar 2015).
10. Association of British Pharmaceutical Industry. Code of practice for the pharmaceutical industry 2014 together with the prescription medicines code of practice authority constitution and procedure. London: ABPI, 2014.
11. Association of British Pharmaceutical Industry. ABPI joint working toolkit. Association of British Pharmaceutical Industry. 2014 (cited 14 A.D. Aug 19). http://www.abpi.org.uk/our-work/news/2012/Pages/140512.aspx
12. Department of Health. Moving beyond sponsorship: Interactive toolkit for joint working between the NHS and the pharmaceutical industry. Department of Health. 2014. (cited 14 A.D. August 19). http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications PolicyAndGuidance/DH-082840
13. Patients academy website. http://www.patientsacademy.eu (accessed 17 Mar 2015).
14. EuroStat. 2013. http://epp.eurostat.ec.europa.eu/tgm/table.do? tab=table&language=en&pcode=teilm020&tableSelection=1& plugin=1 27 January 2014.
15. GFK Emer Ad Hoc Research website. 2015. http://www.gfk.com (accessed 17 Mar 2015).
16. CEM Market and Public Opinion Research Institute. 2015. http://www.cem.pl (accessed 17 Mar 2015).
17. Richie J, Lewis J. Qualitative research practice.4th edn. London: Sage, 2011.
18. Pollard K, Donskoy AL, Moule P, et al. Developing and evaluating guidelines for patient and public involvement (PPI) in research. Int J Health Care Qual Assur 2015;28:141-55.
19. Involve. Developing training and support for public involvement in research. Southampton: NIHR, 2012. http://www.invo.org.uk/wp-content/uploads/2012/11/INVOLVETrainingSupport2012.pdf
20. European Commission. Eurobarometer qualitative study-Patient involvement. Brussels: European Commission, 2012.
21. Roger EM. Diffusion of Innovations. 4th edn. New York: Simon and Schuster, 2010.
22. Ipsos Mori Public Affairs. Reputation snapshot for the pharmaceutical sector. London, 2012. http://www.ipsos.com/public-affairs/sites/www.ipsos.com.public-affairs/files/Pharma% 20Reputation%20Snapshot%20-%INTL.pdf (accessed 17 Mar 15).
23. Patient involvement in drug development-from theory to reality. http://www.patientsacademy.eu/index.php/en/news/press-area/press-releases/361-patient-involvement-in-industry-r-d-from-theory-to-reality (accessed 17 Mar 2015).
24. Hoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines: A call for action. Therapeutic Innovation and Regulatory Science. 1-11, 2015. http://dij.sagepub.com/content/early/2015/04/24/2168479015580384. full.pdf?ijkey=BMyiC3ykhZNg5cd&keytype=finite (accessed 11 May 15).